T/ZPP 128-2025 Active Group standards

T/ZPP 128-2025 Anti-cancer monoclonal antibody technology requirements

Publish Date: 2025-06-19 Implement Date: 2025-06-30 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/ZPP 128-2025

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Drugs

Publish Date: 2025-06-19

Implement Date: 2025-06-30

Scope

Scope: This document is applicable to anti-cancer monoclonal antibodies; Main technical content: This document specifies the terms and definitions of anti-cancer monoclonal antibodies, basic principles, requirements for drug design and development, production process requirements, quality control requirements, efficacy and safety requirements, stability studies, compliance requirements, and risk management-related requirements.